BLM and colorectal carcinoma: A recent meta-analysis combining our own BLM mutational screening with previous studies and publicly available sequencing data from familial and/or early onset CRC patients suggested a lack of association of BLM heterozygous disruptive and predicted pathogenic variants with CRC predisposition after comparison with the frequencies in population controls [10].